Alexander F. Vom Stein

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Chronic Lymphocytic Leukemia Through the Spectrum: Frontline Therapy, Sequencing With Subsequent Therapy, and Treatment of Double-Refractory Patients.

Chronic Lymphocytic Leukemia Through the Spectrum: Frontline Therapy, Sequencing With Subsequent Therapy, and Treatment of Double-Refractory Patients.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: May 28, 2026

Reduced colony-stimulating factor 1 receptor expression in myeloid cells has limited impact on chronic lymphocytic leukaemia progression.

Reduced colony-stimulating factor 1 receptor expression in myeloid cells has limited impact on chronic lymphocytic leukaemia progression.

Journal: British journal of haematology

Published: January 21, 2026

Understanding and Targeting BCL2-inhibitor Resistance in Chronic Lymphocytic Leukemia.

Understanding and Targeting BCL2-inhibitor Resistance in Chronic Lymphocytic Leukemia.

Journal: Hematology/oncology clinics of North America

Published: July 22, 2025

A question of TiME: how microenvironmental interactions shape response to immunotherapy in CLL and Richter Transformation.

A question of TiME: how microenvironmental interactions shape response to immunotherapy in CLL and Richter Transformation.

Journal: Frontiers in immunology

Published: March 12, 2025

Comparative analysis of macrophage feeder systems reveals distinct behaviors and key transcriptional shifts in chronic lymphocytic leukemia cells via coculture.

Comparative analysis of macrophage feeder systems reveals distinct behaviors and key transcriptional shifts in chronic lymphocytic leukemia cells via coculture.

Journal: HemaSphere

Published: March 03, 2025

The immune landscape in brain metastasis.

The immune landscape in brain metastasis.

Journal: Neuro-oncology

Published: October 15, 2024

Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia.

Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia.

Journal: Blood

Published: December 13, 2023

Role of the tumor microenvironment in CLL pathogenesis.

Role of the tumor microenvironment in CLL pathogenesis.

Journal: Seminars in hematology

Published: November 07, 2023

Non-viral TRAC-knocked-in CD19KICAR-T and gp350KICAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency.

Non-viral TRAC-knocked-in CD19KICAR-T and gp350KICAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency.

Journal: Frontiers in immunology

Published: November 01, 2022

Stromal cells support the survival of human primary chronic lymphocytic leukemia (CLL) cells through Lyn-driven extracellular vesicles.

Stromal cells support the survival of human primary chronic lymphocytic leukemia (CLL) cells through Lyn-driven extracellular vesicles.

Journal: Frontiers in medicine

Published: September 30, 2022

LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1.

LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1.

Journal: Nature communications

Published: March 14, 2022

The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia.

The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia.

Journal: Leukemia

Published: October 06, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026